Boule Diagnostics
10 SEK 0%1 investor is following this company
Boule Diagnostics is a diagnostics company. The company develops, manufactures, and sells medical technology systems and consumables for blood cell counts to the healthcare industry. The greatest focus is on small and medium-sized hospitals, clinics, and laboratories, as well as on other diagnostic companies in both human and veterinary hematology. Operations are located in the European market, with headquarters in Spånga.
Revenue
571.3M
EBIT %
6.88 %
P/E
15.63
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BOUL
Daily low / high price
10 / 10.45
SEK
Market cap
388.33M SEK
Turnover
132.93K SEK
Volume
13K
Financial calendar
Interim report
2024-05-07
General meeting
2024-05-08
Interim report
2024-07-22
Interim report
2024-10-25
Annual report
2025-02-11
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
AB Grenspecialisten | 12.6 % | 12.6 % |
Svolder | 11.0 % | 11.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Boule Diagnostics AB: Boule Diagnostics publicerar årsredovisningen för 2023
Boule Diagnostics AB: Torben Nielsen tillträder som VD för Boule Diagnostics 16 april 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools